BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 9703911)

  • 21. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
    Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.
    Bhargava P; Marshall JL; Dahut W; Rizvi N; Trocky N; Williams JI; Hait H; Song S; Holroyd KJ; Hawkins MJ
    Clin Cancer Res; 2001 Dec; 7(12):3912-9. PubMed ID: 11751482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Modulation of the antitumor effect of cyclophosphamide by the recombinant probiotic Subalin].
    Cherdyntseva NV; Litviakov NV; Smol'ianinov ES; Beliavskaia VA; Masycheva VI
    Vopr Onkol; 1997; 43(3):313-6. PubMed ID: 9245089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
    Emerman JT; Siemiatkowski J
    Cancer Res; 1984 Apr; 44(4):1327-32. PubMed ID: 6704951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma.
    Teicher BA; Alvarez E; Liu P; Lu K; Menon K; Dempsey J; Schultz RM
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):55-62. PubMed ID: 10598556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
    Zhang R; Tian L; Chen LJ; Xiao F; Hou JM; Zhao X; Li G; Yao B; Wen YJ; Li J; Zhang L; Chen XC; Luo F; Peng F; Jiang Y; Wei YQ
    Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma.
    Anderson IC; Shipp MA; Docherty AJ; Teicher BA
    Cancer Res; 1996 Feb; 56(4):715-8. PubMed ID: 8631001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models.
    Emanuel S; Gruninger RH; Fuentes-Pesquera A; Connolly PJ; Seamon JA; Hazel S; Tominovich R; Hollister B; Napier C; D'Andrea MR; Reuman M; Bignan G; Tuman R; Johnson D; Moffatt D; Batchelor M; Foley A; O'Connell J; Allen R; Perry M; Jolliffe L; Middleton SA
    Mol Pharmacol; 2004 Sep; 66(3):635-47. PubMed ID: 15322256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined low-dose chemotherapy inhibiting angiogenesis and growth of Lewis lung cancinoma xenografts in mice].
    Qiu M; Yi C; Hou M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):534-7. PubMed ID: 16909595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
    Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
    Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
    Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
    J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
    Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
    Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.
    Teicher BA; Sotomayor EA; Huang ZD
    Cancer Res; 1992 Dec; 52(23):6702-4. PubMed ID: 1384969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proteasome inhibitor PS-341 in cancer therapy.
    Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J
    Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of local tumor growth with paclitaxel-loaded microspheres.
    Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.
    Datta A; Kitson RP; Xue Y; al-Atrash G; Mazar AP; Jones TR; Goldfarb RH
    In Vivo; 2002; 16(6):451-7. PubMed ID: 12494889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
    Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of metastasis by cicaprost in rats with established SMT2A mammary carcinoma growth.
    Schirner M; Schneider MR
    Cancer Detect Prev; 1997; 21(1):44-50. PubMed ID: 9043762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antitumor effects of recombinant quail vascular endothelial growth factor receptor 2, as a vaccine, combined with cisplatin on LL/2 tumor model in mice].
    Hou JM; Liu JY; Yang L; Zhao X; Tian L; Lei S; Mao YQ; Wen YJ; Wei YQ
    Ai Zheng; 2005 Apr; 24(4):391-6. PubMed ID: 15820058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.